Your browser doesn't support javascript.
loading
TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer.
Agarwal, Neeraj; Rinaldetti, Sebastien; Cheikh, Bassem B; Zhou, Qiong; Hass, Evan P; Jones, Robert T; Joshi, Molishree; LaBarbera, Daniel V; Knott, Simon R V; Cech, Thomas R; Theodorescu, Dan.
Affiliation
  • Agarwal N; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
  • Rinaldetti S; Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA 90048.
  • Cheikh BB; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
  • Zhou Q; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
  • Hass EP; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
  • Jones RT; Department of Biochemistry, University of Colorado, Boulder, CO 80303.
  • Joshi M; BioFrontiers Institute, University of Colorado, Boulder, CO 80303.
  • LaBarbera DV; Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045.
  • Knott SRV; Functional Genomics Facility, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
  • Cech TR; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.
  • Theodorescu D; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
Proc Natl Acad Sci U S A ; 118(38)2021 09 21.
Article in En | MEDLINE | ID: mdl-34518220

Full text: 1 Database: MEDLINE Main subject: Transcription Factors / Transcription, Genetic / Urinary Bladder Neoplasms / Promoter Regions, Genetic / Telomerase / Tripartite Motif-Containing Protein 28 / Mutation Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Transcription Factors / Transcription, Genetic / Urinary Bladder Neoplasms / Promoter Regions, Genetic / Telomerase / Tripartite Motif-Containing Protein 28 / Mutation Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article